As expected from the relaxed sequence specificity of γ-secretase, a wide range of type I transmembrane substrates has been described within the last few years, extending a physiological role for PS1 beyond the nervous system and AD (Fig. 2). Here, PSEN1 is linked to Alzheimer disease.